PC-558 A Phase 1, Double-Blind, Parallel, Placebo-Controlled, Randomized Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Acceptibility of PC-1005 (MIV-150/ZA in a Carrageenan Vehicle) Microbicide Gel Formulation in HIV- Seronegative Women

Grant

Date/time Interval

  • April 1, 2014 - May 31, 2015
  • Awarded By

    Total Award Amount

  • 462709.00
  • Direct Costs

  • 346566.00
  • Sponsor Award Id

  • SH1411
  • Contributor

  • Craig Hoesley   Principal Investigator